This is a working overview of hygroscopicity, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-11-11. Anything still debated is marked as such rather than presented as settled.
Quality control for collagen peptides may include identity, purity, and contaminant testing. Identity can be supported by amino acid profile and hydroxyproline content; purity checks may examine moisture, ash, protein content, and peptide size range. Heavy metals, microbial counts, and residual solvents are relevant for materials intended for ingestion. Some suppliers use peptide fingerprinting or source-specific markers, though these methods are not universally standardized. Documentation such as certificates of analysis helps verify that a batch meets agreed specifications.
Analytical characterization of collagen peptides often begins with peptide size distribution. Size-exclusion chromatography can separate peptides by hydrodynamic volume, while mass spectrometry provides more detailed mass information. Amino acid analysis quantifies residues such as glycine, proline, and hydroxyproline. Hydroxyproline assays are widely used because this amino acid is uncommon in many other proteins; nitrogen content and ash values help assess purity and residual minerals. No single method captures all relevant properties, so laboratories commonly combine several techniques.
Stability depends on moisture, temperature, oxygen, and packaging. Dry collagen peptide powders are generally stable when kept cool and dry, but humid conditions can cause clumping and microbial growth. Heat exposure may promote Maillard reactions if reducing sugars are present, altering color and flavor. Solutions are less stable than powders and may support microbial proliferation unless preserved or refrigerated; light exposure can also affect appearance over time. Shelf-life claims vary and should be supported by real-time or accelerated stability data.
Collagen peptides are hygroscopic and can cake or lose flowability when exposed to moisture. Typical storage is in sealed containers at ambient temperature, away from direct sunlight and strong odors. High humidity and prolonged heat may increase Maillard browning, off-odors, or microbial risk. Food-grade specifications commonly set limits for moisture, ash, heavy metals, and total plate count. Stability studies often monitor appearance, moisture, molecular mass profile, and microbial counts over defined intervals.
Identity and purity testing for collagen peptides combines general protein assays with methods sensitive to collagen-specific features. Hydroxyproline content is often measured colorimetrically after acid hydrolysis and serves as a marker of collagen origin. Total nitrogen or Kjeldahl analysis estimates protein content but does not distinguish peptides from other nitrogenous compounds. Amino acid analysis provides a compositional fingerprint, while SDS-PAGE and size-exclusion chromatography reveal molecular weight ranges. No single method captures all quality attributes, so specifications typically combine several orthogonal tests.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | 15–25 °C | Keep dry and protect from direct light |
| Moisture content | ≤ 6–8% | Higher moisture can reduce stability |
| Solubility class | Water-soluble | Insoluble in nonpolar solvents |
| Common analytical method | Size-exclusion chromatography | Used for molecular weight distribution |
| Microbial limits | Total aerobic count < 10³ CFU/g | Specifications vary by market and application |
Storage and handling of collagen peptides require protection from moisture, heat, and light. The powders are hygroscopic and can absorb water from the air, leading to clumping or microbial growth. Typical storage conditions are a cool, dry place at room temperature or below, in tightly sealed containers. Some manufacturers recommend refrigeration for long-term stability. Solutions prepared from the powder are less stable and should be used promptly or preserved according to validated protocols.
Production of collagen peptides begins with raw materials such as bovine hide, porcine skin, fish scales, or poultry cartilage. The collagen is extracted, often with acid or alkaline treatment, and then subjected to hydrolysis using enzymes like pepsin or alcalase, or chemical agents. Enzymatic hydrolysis is favored for its mild conditions and controllability. The resulting mixture is filtered, concentrated, and dried to yield a powder. Process parameters such as temperature, pH, and enzyme-to-substrate ratio determine the molecular weight profile and yield.
Analytical methods for collagen peptides focus on molecular weight distribution, amino acid composition, and purity. Size exclusion chromatography with UV detection is widely used to estimate molecular weight ranges. High-performance liquid chromatography can quantify hydroxyproline after acid hydrolysis. Mass spectrometry provides detailed sequence information for individual peptides. Other tests include moisture content, ash, heavy metals, and microbial limits. The choice of method depends on the specific quality attribute and the required sensitivity.
Dry collagen peptide powder is generally stable when kept in a sealed container away from moisture, heat, and direct sunlight. The powder is hygroscopic and can clump if exposed to humid air, so desiccant packets are sometimes included. In solution, collagen peptides are susceptible to microbial growth unless preserved or refrigerated. Prolonged exposure to high temperatures may cause aggregation or color changes. Typical storage recommendations are cool and dry conditions at ambient temperature.
Quality control for collagen peptides includes measurements of moisture content, ash, protein content, and heavy metals. Microbial limits are set to ensure food or cosmetic grade safety, and the degree of hydrolysis serves as a key process indicator. That indicator correlates with molecular weight distribution and solubility characteristics. Regulatory requirements vary by country, and some jurisdictions restrict label claims about health effects. Documentation such as certificates of analysis and safety data sheets typically accompanies commercial shipments of the material.
Analytical testing of collagen peptides focuses on identity, purity, and molecular weight profile. Size-exclusion chromatography separates peptides by hydrodynamic volume and is often calibrated with known protein standards. Amino acid analysis after acid hydrolysis provides the compositional profile, which can confirm the collagen origin. Mass spectrometry offers detailed sequence information for individual peptides. These methods together help ensure that a product matches its specification and that batch-to-batch variability is controlled.
Intravenous and oral formulations of acetylcysteine are available for the treatment of paracetamol (acetaminophen) overdose. When paracetamol is taken in large quantities, a toxic minor metabolite called N-acetyl-p-benzoquinone imine (NAPQI) accumulates within the body. It is normally conjugated by glutathione (GSH), but when taken in excess, the body's glutathione reserves are not sufficient to deactivate the toxic NAPQI. This metabolite is then free to react with key hepatic enzymes, thereby damaging liver cells. This may lead to severe liver damage and even death by acute liver failure. Liver necrosis is observed in animals at ~70% GSH depletion, and normal liver GSH is approximately 4 mmol/L. In the treatment of paracetamol (acetaminophen) overdose, acetylcysteine acts to maintain or replenish depleted glutathione reserves in the liver and enhance non-toxic metabolism of acetaminophen. These actions serve to protect liver cells from NAPQI toxicity. It is most effective in preventing or lessening hepatic injury when administered within 8–10 hours after overdose. Research suggests that the rate of liver toxicity is approximately 3% when acetylcysteine is administered within 10 hours of overdose. To decide whether NAC treatment is warranted, the Rumack–Matthew nomogram may be consulted.
The drug udenafil is marketed under the trade name Zydena. It is within the PDE5 inhibitor class (which also includes avanafil, sildenafil, tadalafil, and vardenafil). Like other PDE5 inhibitors, it is used to treat erectile dysfunction. Udenafil was developed by Dong-A Pharmaceutical. It has fairly rapid onset of action (peak plasma concentration after 1 to 1.5 hours), and has long duration of action (plasma half-life of 11 to 13 hours). Udenafil's pharmacokinetics allows once-daily dosage (in addition to on-demand use). Typical doses are 100 and 200 mg. Udenafil is available in Korea, Russia, and the Philippines. It has not yet been approved for use in the United States by the U.S. Food and Drug Administration.
Attention is being turned to the still difficult, but less unpromising, problem of radio detection and numerical considerations on the method of detection by reflected radio waves will be submitted when required. The letter was discussed at the first official meeting of the Tizard Committee on 28 January 1935. The utility of the concept was evident to all attending, but the question remained whether it was actually possible. Albert Rowe and Wimperis both checked the maths and it appeared to be correct. They immediately wrote back asking for a more detailed consideration. Watt and Wilkins followed up with a 14 February secret memo entitled Detection and Location of Aircraft by Radio Means. In the new memo, Watson-Watt and Wilkins first considered various natural emanations from the aircraft – light, heat and radio waves from the engine ignition system – and demonstrated that these were too easy for the enemy to mask to a level that would be undetectable at reasonable ranges. They concluded that radio waves from their own transmitter would be needed. Wilkins gave specific calculations for the expected reflectivity of an aircraft. The received signal would be only 10−19 times as strong as the transmitted one, but such sensitivity was considered to be within the state of the art. To reach this goal, a further improvement in receiver sensitivity of two times was assumed.
Germany has a civil law system based on Roman law with some references to Germanic law. The Bundesverfassungsgericht (Federal Constitutional Court) is the German Supreme Court responsible for constitutional matters, with power of judicial review. Germany's specialised supreme court system includes the Federal Court of Justice for civil and criminal cases, along with the Federal Labour Court, Federal Social Court, Federal Fiscal Court, and Federal Administrative Court for other matters. Criminal and private laws are codified on the national level in the Strafgesetzbuch and the Bürgerliches Gesetzbuch respectively. The German penal system seeks the rehabilitation of the criminal and the protection of the public. With the exceptions of petty crimes, tried by a single professional judge, and of serious political crimes, all charges are adjudicated by mixed tribunals where lay judges (Schöffen) and professional judges preside together. In 2016, Germany's murder rate stood at a low of 1.18 murders per 100,000. In 2018, the overall crime rate in the country fell to its lowest since 1992, while in 2024, it was reported that violent crime reached a 15-year high, with overall crime rising as well. Same-sex marriage in Germany has been legal since 2017, and LGBT rights in the country are generally protected.
==== European Union ==== The European Board of Internal Medicine (EBIM) was formed as a collaborative effort between the European Union of Medical Specialists (UEMS) - Internal Medicine Section and the European Federation of Internal Medicine (EFIM) to provide guidance on standardizing training and practice of internal medicine throughout Europe. The EBIM published training requirements in 2016 for postgraduate education in internal medicine, and efforts to create a European Certificate of Internal Medicine (ECIM) to facilitate the free movement of medical professionals with the EU are currently underway. The internal medicine specialist is recognized in every country in the European Union and typically requires five years of multi-disciplinary post-graduate education. The specialty of internal medicine is seen as providing care in a wide variety of conditions involving every organ system and is distinguished from family medicine in that the latter provides a broader model of care the includes both surgery and obstetrics in both adults and children.
Sources: en.wikipedia.org
The MasSpec Pen is a mass spectrometry (MS) based cancer detection and diagnosis system that can be used for ex vivo and in vivo tissue sample analysis. The system collects biological molecules from a tissue sample surface via a solid-liquid extraction mechanism and transports the molecules to a mass spectrometer for analysis. The composition of the extracted molecules can then be used to predict if the tissue sample analyzed contains cancerous cells using machine learning algorithms and statistical models. In early-stage clinical research, the MasSpec Pen system was able to distinguish various cancer tissues, including thyroid, breast, lung, and ovarian tumor tissues, from their normal counterparts with an overall accuracy of 96.3%. A follow-up study in illustrating the use of the device for detection of serous ovarian carcinoma in ex vivo tissue biopsies allowed for the discrimination of normal and cancerous ovarian samples with a clinical sensitivity and specificity of 94.0% and 94.4%, respectively.
==== Metabolism and elimination ==== Hepatic – the primary metabolite is 4-carboxypyrazole (about 80 to 85% of an administered dose). Other metabolites include the pyrazoles 4-hydroxymethylpyrazole and the N -glucuronide conjugates of 4-carboxypyrazole and 4-hydroxymethylpyrazole. Following multiple doses, fomepizole rapidly induces its own metabolism via the cytochrome P450 mixed-function oxidase system. In healthy volunteers, 1.0 to 3.5% of an administered dose was excreted unchanged in the urine. The metabolites also are excreted unchanged in the urine. Fomepizole is dialyzable.
== History == The first medical use of fumaric acid was described in 1959 by Walter Schweckendiek, a German chemist, and was a topical formulation for psoriasis. The Swiss company Fumapharm eventually brought Fumaderm, an oral formulation of dimethyl fumarate (along with some monoesters) to market for psoriasis in Germany in 1994. Based on the efficacy and safety of this formulation, and evidence that dimethyl fumarate was the main active component, an oral formulation of dimethyl fumarate was developed by Almirall. This oral formulation, under the brand name Skilarence, was approved by the European Medicines Agency (EMA) in June 2017, for the treatment of moderate-to-severe plaque psoriasis in adults. Initial clinical research on the use of dimethyl fumarate for the treatment of multiple sclerosis was conducted by Fumapharm in collaboration with Biogen Idec; Fumapharm was subsequently acquired by Biogen Idec in 2006. Aditech Pharma in Sweden had also been researching oral formulations of dimethyl fumarate for MS and in 2010, the Danish company Forward Pharma acquired Aditech's patents. Biogen continued developing its oral formulation of dimethyl fumarate from Fumapharm under the code name BG-12; it was approved, under the trade name Tecfidera, for the treatment of adults with relapsing forms of MS in March 2013. Biogen priced the drug at $54,000 per year in the US. It was approved in Europe in 2014.
== Signs and symptoms == Head pain occurs in 50–75% of all cases of vertebral artery dissection. It tends to be located at the back of the head, either on the affected side or in the middle, and develops gradually. It is either dull or pressure-like in character or throbbing. About half of those with VAD consider the headache distinct, while the remainder have had a similar headache before. It is suspected that VAD with headache as the only symptom is fairly common; 8% of all cases of vertebral and carotid dissection are diagnosed on the basis of pain alone. Obstruction of blood flow through the affected vessel may lead to dysfunction of part of the brain supplied by the artery. This happens in 77–96% of cases. This may be temporary ("transient ischemic attack") in 10–16% of cases, but many (67–85% of cases) end up with a permanent deficit or a stroke. The vertebral artery supplies the part of the brain that lies in the posterior fossa of the skull, and this type of stroke is therefore called a posterior circulation infarct. Problems may include difficulty speaking or swallowing (lateral medullary syndrome); this occurs in less than a fifth of cases and occurs due to dysfunction of the brainstem. Others may experience unsteadiness or lack of coordination due to involvement of the cerebellum, and still others may develop visual loss (on one side of the visual field) due to involvement of the visual cortex in the occipital lobe.
== Properties == Protolichesterinic acid is a member of the class of chemicals known as lactone fatty acids, a group that includes lichesterinic acid, alloprotolichesterinic acid, nephromopsinic acid, and nephrosterinic acid. In its purified form, protolichesterinic acid is a crystalline solid that forms lustrous plates when recrystallized from benzene or acetic acid at temperatures below 50 °C (122 °F). It has a melting point of 107.5 °C (225.5 °F). The compound exists in both enantiomeric forms, with the (+)-enantiomer showing an optical rotation of [α]D +12° in chloroform and the (-)-enantiomer showing [α]D -12° in chloroform. In ultraviolet–visible spectroscopy, it shows maximum absorption at 218 nm in methanol. Its infrared spectrum (KBr) shows characteristic peaks including those corresponding to carboxylic acid (3450 cm−1), alkene (3050 cm−1), and carbonyl (1720 cm−1) functionalities. Nuclear magnetic resonance spectroscopy confirms its structure, with distinctive signals in the 1H NMR spectrum including the terminal methyl group at δ 0.68 ppm and alkene protons at δ 6.03 and 6.39 ppm. The 13C NMR spectrum shows key resonances for the carboxylic acid (174.4 ppm), alkene (132.6 and 125.9 ppm), and lactone carbonyl (168.2 ppm) carbons.
Sources: en.wikipedia.org
Common methods include size-exclusion chromatography and mass spectrometry. Amino acid analysis provides composition data but not chain length. Results depend on calibration standards and sample preparation.
A cool, dry place protected from moisture and direct light is typical. Sealed containers help prevent clumping and contamination. Solution forms usually require refrigeration or preservatives.
It may report appearance, moisture, ash, protein content, molecular weight distribution, and microbial limits. Heavy metal results and amino acid profiles are also common. The exact panel depends on the supplier and intended use.
Purity is assessed through a combination of protein content, hydroxyproline, amino acid composition, and chromatographic profile. Moisture, ash, and microbial tests cover non-protein impurities and handling quality.